Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitased is a herbal dietary supplement developed and marketed by the Ukrainian pharmaceutical company Ecopharm. It is formulated as a sedative and mild cardiotonic complex, typically containing standardized extracts of Valerian (*Valeriana officinalis*), Motherwort (*Leonurus cardiaca*), and Hawthorn (*Crataegus*). The product is intended to support the functional state of the nervous and cardiovascular systems during periods of increased emotional stress, irritability, and sleep disturbances. Its mechanism of action relies on the synergistic effects of its botanical components, which modulate GABAergic signaling to provide calming effects and offer mild vasodilatory properties to support heart health. It is primarily used to alleviate symptoms of anxiety, tension, and insomnia without the heavy sedative profile of synthetic pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitased.